NanoString Technologies, Inc. (NASDAQ:NSTG) Given Consensus Rating of “Hold” by Analysts

Shares of NanoString Technologies, Inc. (NASDAQ:NSTGGet Free Report) have been assigned a consensus recommendation of “Hold” from the six brokerages that are presently covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $7.63.

Separately, StockNews.com assumed coverage on shares of NanoString Technologies in a report on Wednesday. They set a “sell” rating on the stock.

Check Out Our Latest Analysis on NSTG

NanoString Technologies Price Performance

The stock has a 50 day moving average of $0.36 and a 200-day moving average of $1.11. The company has a market capitalization of $5.07 million, a P/E ratio of -0.03 and a beta of 1.24. NanoString Technologies has a 12 month low of $0.05 and a 12 month high of $11.78.

Institutional Trading of NanoString Technologies

Several institutional investors have recently made changes to their positions in NSTG. Point72 Middle East FZE purchased a new position in NanoString Technologies in the 4th quarter worth approximately $29,000. Point72 Hong Kong Ltd bought a new stake in shares of NanoString Technologies during the second quarter valued at approximately $57,000. Advisor Group Holdings Inc. lifted its holdings in shares of NanoString Technologies by 21.1% in the first quarter. Advisor Group Holdings Inc. now owns 4,595 shares of the biotechnology company’s stock worth $162,000 after buying an additional 800 shares in the last quarter. Natixis bought a new position in shares of NanoString Technologies during the fourth quarter worth $39,000. Finally, Tower Research Capital LLC TRC boosted its position in shares of NanoString Technologies by 181.5% during the third quarter. Tower Research Capital LLC TRC now owns 5,705 shares of the biotechnology company’s stock worth $73,000 after acquiring an additional 3,678 shares during the last quarter.

NanoString Technologies Company Profile

(Get Free Report

NanoString Technologies, Inc develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system.

See Also

Analyst Recommendations for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.